As of 2026-03-19, the Relative Valuation of Gossamer Bio Inc (GOSS) is (14.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.43 USD, the upside of Gossamer Bio Inc based on Relative Valuation is -3339.9%.
The range of the Relative Valuation is (12.64) - (14.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 23.0x | 20.6x |
| Forward P/E multiples | 17.9x - 21.7x | 21.1x |
| Fair Price | (12.64) - (14.64) | (14.06) |
| Upside | -3012.0% - -3472.0% | -3339.9% |
| Date | P/E |
| 2026-03-12 | -0.68 |
| 2026-03-11 | -0.73 |
| 2026-03-10 | -0.75 |
| 2026-03-09 | -0.82 |
| 2026-03-06 | -0.74 |
| 2026-03-05 | -0.77 |
| 2026-03-04 | -0.86 |
| 2026-03-03 | -0.70 |
| 2026-03-02 | -0.64 |
| 2026-02-27 | -0.63 |
| 2026-02-26 | -0.60 |
| 2026-02-25 | -0.56 |
| 2026-02-24 | -0.62 |
| 2026-02-23 | -0.63 |
| 2026-02-20 | -3.16 |
| 2026-02-19 | -3.13 |
| 2026-02-18 | -3.22 |
| 2026-02-17 | -3.19 |
| 2026-02-13 | -3.39 |
| 2026-02-12 | -3.44 |
| 2026-02-11 | -3.48 |
| 2026-02-10 | -3.45 |
| 2026-02-09 | -3.35 |
| 2026-02-06 | -3.35 |
| 2026-02-05 | -3.61 |
| 2026-02-04 | -3.65 |
| 2026-02-03 | -3.96 |
| 2026-02-02 | -3.68 |
| 2026-01-30 | -3.38 |
| 2026-01-29 | -3.59 |
| 2026-01-28 | -3.78 |
| 2026-01-27 | -3.91 |
| 2026-01-26 | -3.94 |
| 2026-01-23 | -4.00 |
| 2026-01-22 | -4.25 |
| 2026-01-21 | -4.06 |
| 2026-01-20 | -3.85 |
| 2026-01-16 | -3.74 |
| 2026-01-15 | -3.63 |
| 2026-01-14 | -3.78 |
| 2026-01-13 | -3.94 |
| 2026-01-12 | -3.74 |
| 2026-01-09 | -3.71 |
| 2026-01-08 | -3.71 |
| 2026-01-07 | -3.57 |
| 2026-01-06 | -3.80 |
| 2026-01-05 | -4.06 |
| 2026-01-02 | -4.27 |
| 2025-12-31 | -4.60 |
| 2025-12-30 | -4.63 |